Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Premarket Review Approval For COVID-19 Test Is US FDA's First For OTC Respiratory Diagnostic

Jun 06 2023

• By Malcolm Spicer

• Source: Shutterstock

Related Content

ROI For US With FDA's Emergency Use Approval Of Cue Health's OTC At-Home COVID-19 Test

Mar 08 2021

FDA Prioritizes Emergency-Use Reviews For Coronavirus At-Home Tests, Doubles Review Staff

Jun 18 2020

US Government Awards $481M To Help Cue Health Expand COVID-19 Test Production

Oct 14 2020

Additional Topics

International United States US States Coronavirus COVID-19 OTC Devices Approvals Advertising, Marketing & Sales Business Strategies Compliance Consumer Commercial Companies FDA Policy Regulation Retail

More from International

More from Geography

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.